Below are
a few key patent figures that we presented in the February 2016 report.
Not exact matches
Such big winners stopped showing up a
few years ago, leaving the large drug companies watching the calendar for the day when earnings would be hurt by the loss of
key patent protections.
Brian Feroldi:
Patent expirations on
key drugs have wreaked havoc on many pharma companies» financial statements over the past
few years, but
few companies have been hit as hard as Pfizer (NYSE: PFE).
One example of such a practice in this category is an IP lawyer with a
patent - prosecution practice who has relationships with
key general counsels or lead scientists at a
few companies.
Before expanding on this, I need to review a
few key sections of the
Patent Act, R.S.C., 1985, c. P - 4 (justice.gc.ca).
While he may run across a
few (millions of) pieces of prior art, such a
patent might just be the
key to tempering the insane number of applications the
patent office receives each year.